Evolution of therapy for ALK-positive lung carcinomas: Application of third-generation ALK inhibitors in real clinical practice
Article in Meditsinskiy sovet = Medical Council (June 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Prediction of pharmacokinetics of an anaplastic lymphoma kinase inhibitor in rat and monkey: application of physiologically based pharmacokinetic model as an alternative tool to minimise animal studies
Article in Xenobiotica (December 2023)
Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review
Article in Translational Lung Cancer Research (June 2021)